Low Residual Proliferation After Short-Term Letrozole Therapy Is an Early Predictive Marker of Response in High Proliferative ER-positive Breast Cancer
Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-11-0180
Full Text
Open PDFAbstract
Available in full text
Date
October 7, 2011
Authors
Publisher
Bioscientifica